Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Applied Health Economics and Health Policy
Published in: Applied Health Economics and Health Policy 1/2017

Open Access 01-02-2017 | Original Research Article

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients

Authors: Yue Zhong, Joshua T. Cohen, Scott Goates, Menghua Luo, Jeffrey Nelson, Peter J. Neumann

Published in: Applied Health Economics and Health Policy | Issue 1/2017

Login to get access

Abstract

Background

Malnutrition, which is associated with increased medical complications in older hospitalized patients, can be attenuated by providing nutritional supplements.

Objective

This study evaluates the cost effectiveness of a specialized oral nutritional supplement (ONS) in malnourished older hospitalized patients.

Methods

We conducted an economic evaluation alongside a multicenter, randomized, controlled clinical trial (NOURISH Study). The target population was malnourished older hospitalized patients in the USA. We used 90-day (base case) and lifetime (sensitivity analysis) time horizons. The study compared a nutrient-dense ONS, containing high protein and β-hydroxy-β-methylbutyrate to placebo. Outcomes included health-care costs, measured as the product of resource use and per unit cost; quality-adjusted life-years (QALYs) (90-day time horizon); life-years (LYs) saved (lifetime time horizon); and the incremental cost-effectiveness ratio (ICER). All costs were inflated to 2015 US dollars.

Results

In the base-case analysis, 90-day treatment group costs averaged US$22,506 per person, compared to US$22,133 for the control group. Treatment group patients gained 0.011 more QALYs than control group subjects, reflecting the treatment group’s significantly greater probability of survival through 90 days’ follow-up, as reported by the clinical trial. Hence, the 90-day follow-up period ICER was US$33,818/QALY. Assuming a lifetime time horizon, estimated treatment group life expectancy exceeded control group life expectancy by 0.71 years. Hence, the lifetime ICER was US$524/LY. The follow-up period for the trial was relatively short. Some of the patients were lost to follow-up, thus reducing collection of health-care utilization data during the clinical trial.

Conclusion

Our findings suggest that the investigative ONS cost-effectively extends the lives of malnourished hospitalized patients.
Literature
1.
Somanchi M, Tao X, Mullin GE. The facilitated early enteral and dietary management effectiveness trial in hospitalized patients with malnutrition. JPEN J Parenter Enteral Nutr. 2011;35(2):209–16.CrossRefPubMed
2.
DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge Survey. Natl Health Stat Rep. 2008;5:1–20.
3.
Agarwal E, Miller M, Yaxley A, Isenring E. Malnutrition in the elderly: a narrative review. Maturitas. 2013;76:296–302.CrossRefPubMed
4.
Corish CA, Kennedy NP. Protein-energy undernutrition in hospital in-patients. Br J Nutr. 2000;83(6):575–91.CrossRefPubMed
5.
Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997;66(2):460S–3S.PubMed
6.
Fry DE, Pine M, Jones BL, Meimban RJ. Patient characteristics and the occurrence of never events. Arch Surg. 2010;145(2):148–51.CrossRefPubMed
7.
Lim SL, Ong KC, Chan YH, Loke WC, Ferguson M, Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr. 2012;31(3):345–50.CrossRefPubMed
8.
Allaudeen N, Vidyarthi A, Maselli J, Auerbach A. Redefining readmission risk factors for general medicine patients. J Hosp Med. 2011;6(2):54–60.CrossRefPubMed
9.
Braunschweig C, Gomez S, Sheean PM. Impact of declines in nutritional status on outcomes in adult patients hospitalized for more than 7 days. J Am Diet Assoc. 2000;100(11):1316–22 (quiz 13 23–4).
10.
Corkins MR, Guenter P, DiMaria-Ghalili RA, Jensen GL, Malone A, Miller S, et al. Malnutrition diagnoses in hospitalized patients: United States, 2010. JPEN J Parenter Enteral Nutr. 2014;38(2):186–95.CrossRefPubMed
11.
Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012;11(2):278–96.CrossRefPubMed
12.
Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev. 2013;12(4):884–97.CrossRefPubMed
13.
Deutz N, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr. 2016;35(1):18–26.CrossRefPubMed
14.
Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8(5):521–33.CrossRefPubMed
15.
16.
17.
Roudsari BS, Ebel BE, Corso PS, Molinari NA, Koepsell TD. The acute medical care costs of fall-related injuries among the U.S. older adults. Injury. 2005;36(11):1316–22.CrossRefPubMed
18.
19.
Mehrotra A, Liu H, Adams J, Wang MC, Lave J, Thygeson NM, et al. The costs and quality of care for three common illnesses at retail clinics as compared to other medical settings. Ann Intern Med. 2009;151(5):321–8.CrossRefPubMedPubMedCentral
20.
21.
Hillman AL, Kim MS. Economic decision making in healthcare. A standard approach to discounting health outcomes. Pharmaco. Economics. 1995;7(3):198–205.
22.
Severens JL, Milne RJ. Discounting health outcomes in economic evaluation: the ongoing debate. Value Health. 2004;7(4):397–401.CrossRefPubMed
23.
Cho H, Klabunde CN, Yabroff KR, Wang Z, Meekins A, Lansdorp-Vogelaar I, et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies. Ann Intern Med. 2013;159(10):667–76.CrossRefPubMed
24.
Neelemaat F, Bosmans JE, Thijs A, Seidell JC, van Bokhorst-de van der Schueren MA. Oral nutritional support in malnourished elderly decreases functional limitations with no extra costs. Clinical nutrition. 2012;31(2):183–90.CrossRefPubMed
25.
Norman K, Pirlich M, Smoliner C, Kilbert A, Schulzke JD, Ockenga J, et al. Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study. Eur J Clin Nutr. 2011;65(6):735–42.CrossRefPubMed
26.
Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness–the curious resilience of the US$50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796–7.CrossRefPubMed
27.
Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
28.
O’Brien CL, Gage BF. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. JAMA. 2005;293(6):699–706.CrossRefPubMed
29.
Desai AA, Baras J, Berk BB, Nakajima A, Garber AM, Owens D, et al. Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis. Arch Intern Med. 2008;168(16):1761–7.CrossRefPubMed
30.
Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med. 2006;31(1):72–9.CrossRefPubMed
31.
Pignone M, Earnshaw S, Pletcher MJ, Tice JA. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med. 2007;167(3):290–5.CrossRefPubMed
32.
33.
Pirlich M, Schutz T, Norman K, Gastell S, Lubke HJ, Bischoff SC, et al. The German hospital malnutrition study. Clin Nutr. 2006;25(4):563–72.CrossRefPubMed
34.
Bauer JD, Isenring E, Torma J, Horsley P, Martineau J. Nutritional status of patients who have fallen in an acute care setting. J Hum Nutr Diet. 2007;20(6):558–64.CrossRefPubMed
35.
Naber TH, Schermer T, de Bree A, Nusteling K, Eggink L, Kruimel JW, et al. Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr. 1997;66(5):1232–9.PubMed
36.
37.
Planas M, Audivert S, Perez-Portabella C, Burgos R, Puiggros C, Casanelles JM, et al. Nutritional status among adult patients admitted to an university-affiliated hospital in Spain at the time of genoma. Clin Nutr. 2004;23(5):1016–24.CrossRefPubMed
38.
Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013;19(2):121–8.PubMed
39.
Allard JP, Keller H, Jeejeebhoy KN, Laporte M, Duerksen DR, Gramlich L, et al. Malnutrition at hospital admission-contributors and effect on length of stay: a prospective cohort study from the Canadian malnutrition task force. JPEN J Parenter Enteral Nutr. 2015;40(4):487–97.CrossRefPubMed
40.
Patel V, Romano M, Corkins MR, DiMaria-Ghalili RA, Earthman C, Malone A, et al. Nutrition screening and assessment in hospitalized patients: a survey of current practice in the United States. Nutr Clin Pract. 2014;29(4):483–90.CrossRefPubMed
41.
Volkert D, Berner YN, Berry E, Cederholm T, Coti Bertrand P, Milne A, et al. ESPEN guidelines on enteral nutrition: geriatrics. Clin Nutr. 2006;25(2):330–60.CrossRefPubMed
42.
Mueller C, Compher C, Ellen DM, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: Nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011;35(1):16–24.CrossRefPubMed
Metadata
Title
The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients
Authors
Yue Zhong
Joshua T. Cohen
Scott Goates
Menghua Luo
Jeffrey Nelson
Peter J. Neumann
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
Applied Health Economics and Health Policy / Issue 1/2017
Print ISSN: 1175-5652
Electronic ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-016-0269-7

Other articles of this Issue 1/2017

Applied Health Economics and Health Policy 1/2017 Go to the issue

Original Research Article

Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data

Original Research Article

Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease

Original Research Article

A Cost-Utility Analysis of Prostate Cancer Screening in Australia

Original Research Article

Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications

Original Research Article

Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China

Short Communication

Promoting Antibacterial Drug Development: Select Policies and Challenges